Deutsche Bank’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-327,995
| Closed | -$36K | – | 5612 |
|
|
2018
Q4 | $36K | Sell |
327,995
-683,520
| -68% | -$449K | ﹤0.01% | 4596 |
|
|
2018
Q3 | $1.72M | Buy |
1,011,515
+158,083
| +19% | +$283K | ﹤0.01% | 2958 |
|
|
2018
Q2 | $1.48M | Sell |
853,432
-454,611
| -35% | -$786K | ﹤0.01% | 3151 |
|
|
2018
Q1 | $2.39M | Sell |
1,308,043
-853,486
| -39% | -$1.8M | ﹤0.01% | 2741 |
|
|
2017
Q4 | $4.82M | Sell |
2,161,529
-222,471
| -9% | -$553K | ﹤0.01% | 2067 |
|
|
2017
Q3 | $6.91M | Buy |
2,384,000
+1,337,095
| +128% | +$4.56M | ﹤0.01% | 1703 |
|
|
2017
Q2 | $4.66M | Buy |
1,046,905
+738,906
| +240% | +$3.05M | ﹤0.01% | 1975 |
|
|
2017
Q1 | $1.43M | Buy |
307,999
+176,995
| +135% | +$1.03M | ﹤0.01% | 2437 |
|
|
2016
Q4 | $796K | Sell |
131,004
-765,489
| -85% | -$4M | ﹤0.01% | 2858 |
|
|
2016
Q3 | $4.94M | Buy |
896,493
+29,777
| +3% | +$139K | ﹤0.01% | 1734 |
|
|
2016
Q2 | $3.29M | Buy |
866,716
+244,672
| +39% | +$829K | ﹤0.01% | 2056 |
|
|
2016
Q1 | $1.72M | Sell |
622,044
-96,406
| -13% | -$349K | ﹤0.01% | 2475 |
|
|
2015
Q4 | $4.07M | Sell |
718,450
-260,682
| -27% | -$1.59M | ﹤0.01% | 1934 |
|
|
2015
Q3 | $5.19M | Buy |
979,132
+902,736
| +1,182% | +$6.99M | ﹤0.01% | 1789 |
|
|
2015
Q2 | $633K | Buy |
76,396
+6,890
| +10% | +$33.4K | ﹤0.01% | 3266 |
|
|
2015
Q1 | $318K | Sell |
69,506
-42,275
| -38% | -$137K | ﹤0.01% | 3544 |
|
|
2014
Q4 | $339K | Buy |
111,781
+63,139
| +130% | +$187K | ﹤0.01% | 3957 |
|
|
2014
Q3 | $134K | Buy |
48,642
+17,857
| +58% | +$64.8K | ﹤0.01% | 4322 |
|
|
2014
Q2 | $124K | Sell |
30,785
-82,234
| -73% | -$349K | ﹤0.01% | 4428 |
|
|
2014
Q1 | $599K | Buy |
113,019
+13,649
| +14% | +$76.5K | ﹤0.01% | 3219 |
|
|
2013
Q4 | $551K | Sell |
99,370
-404,735
| -80% | -$1.75M | ﹤0.01% | 3039 |
|
|
2013
Q3 | $2.27M | Buy |
504,105
+49,087
| +11% | +$220K | ﹤0.01% | 2395 |
|
|
2013
Q2 | $1.94M | Buy |
+455,018
| New | +$2.29M | ﹤0.01% | 2243 |
|
Other funds holding SGYP
Deutsche Bank's SGYP Position: Q1 2019 in Review
Deutsche Bank sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 327,995 shares — an estimated $36K sold.
Deutsche Bank first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $6.91M in Q3 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Deutsche Bank reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Deutsche Bank sold 327,995 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $36K.
- Deutsche Bank first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Deutsche Bank's Synergy Pharmaceuticals, Inc Common Stock position peaked at $6.91M in Q3 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Deutsche Bank's 13F filing for Q1 2019, filed 15 May 2019.